Abridge
Ambient AI scribe for clinicians — 200+ health systems, Best in KLAS
Overview
Abridge is an ambient AI clinical documentation platform used by large US health systems to convert patient conversations into structured clinical notes in real time, integrated with major EHRs. The company raised a $300M Series E in June 2025 (a16z-led) at a $5.3B valuation, up from $2.75B in February 2025, followed by a reported $316M Series E extension in April 2026 — total funding around $780M from investors including Lightspeed, Bessemer, Kaiser Permanente Ventures and NVIDIA's NVentures. Abridge was named #1 Best in KLAS for Ambient AI in Revenue Cycle Management for two consecutive years (most recently February 2026), alongside its general ambient-AI KLAS recognition.
Pricing
Pricing shown for reference only. These figures reflect RECATOOLS research as of 31 Aug 2026 and may be out of date or incomplete. This is not financial or purchasing advice — always confirm the current price on the provider’s official website before making any decision.
- Quote-based, no public pricing
- Epic-integrated ambient documentation
- Sold to organizations, not individuals
- Per-clinician pricing set by contract scale
- Deep Epic/EHR integration
- Dedicated deployment support
Use cases
What you can produce with Abridge
- Structured clinical note (SOAP or specialty-specific format) generated from a live physician-patient encounter
- Patient after-visit summary in plain, accessible language ready to share at discharge
- ICD-10 / HCC-coded billing documentation extracted automatically from the encounter transcript
- Linked transcript with audio timestamps so every note assertion traces back to the spoken source
- Nursing encounter-to-documentation conversion for inpatient and ambulatory nursing workflows
- Prior-authorization support document with evidence citations drawn from the clinical conversation
- Ambient encounter summary integrated directly into the Epic chart via the Abridge-Epic native connection
ASEAN Perspective
Abridge in Southeast Asia
Abridge is currently a US-market product with no announced APAC presence, no regional data centres, and no known partnerships with hospitals in Southeast Asia, Australia, or the broader APAC region as of mid-2026. All audio and clinical data is processed in US-based servers, creating significant data-sovereignty and patient-consent obstacles under Singapore's PDPA, Malaysia's PDPA, Thailand's PDPC Act, and Australia's Privacy Act — making enterprise adoption by ASEAN health systems legally complex without contractual data-residency guarantees. The platform's 28+ language support theoretically covers Malay, Indonesian, Thai, and Tagalog, but clinical accuracy in these languages has not been independently validated, and there is no Epic footprint in most ASEAN public health systems. ASEAN healthcare providers should treat Abridge as a future-watch product rather than a deployable solution in the near term.
Abridge is the clear market leader in ambient AI documentation for large US health systems, validated by more peer-reviewed research than any competitor, Best in KLAS two consecutive years, and deployments at the most prestigious names in American medicine. Its native Epic embedding, 28+ language support, and evidence-linked note traceability set a quality bar that most rivals have not matched. For organisations already on Epic and able to navigate an enterprise procurement cycle, it is arguably the safest, most clinically credible choice available in 2026.
The caveats are real, however. Abridge is enterprise-only — individual clinicians, small practices, and systems on non-Epic EHRs face significant friction or outright unavailability. Pricing of roughly $2,500 per clinician annually (possibly higher with deeper integrations) is 40–60% above some comparable ambient scribes. All data is processed in US data centres with no confirmed APAC or EU residency options, which creates compliance barriers for healthcare providers outside North America. There is no public API, no self-serve trial, and limited configurability for specialties or workflows not already templated. For health systems weighing cost or operating outside the US, the value equation requires careful scrutiny.
What people say
200-plus health systems are live on Abridge today, with another 100 or so contracted to go live within the next year — real numbers, not the rounder "300+" figure often quoted, per the company's own June 2026 reporting. That growth pace tracks with the accolades: KLAS named Abridge #1 for Ambient AI in Revenue Cycle Management for the second year running in February 2026, scoring 94.7 points with A+ marks on customer loyalty and value, and G2 users rate it 4.7/5.
Clinicians describe real time savings — peer-reviewed studies tied to Abridge report measurable drops in documentation time and after-hours charting, and UPMC alone scaled the platform to 12,000 clinicians enterprise-wide. Native Epic embedding, 28+ language support, and note-level evidence linking are the most consistently praised features across verified reviews.
The friction shows up in inpatient and complex-encounter settings, where feedback turns more mixed, and in access: Abridge sells enterprise-only, with no self-serve tier and no published pricing — third-party estimates range wildly from roughly $150 to $800+ per clinician per month depending on who's asking. For large Epic shops that can clear procurement, it remains the safest bet in ambient documentation; for anyone without an enterprise budget or an Epic install, it isn't reachable at all.
Summary of public user & expert reviews, compiled by RECATOOLS.
Notable facts
- Abridge was born from the Pittsburgh Health Data Alliance — a three-way partnership between Carnegie Mellon University, the University of Pittsburgh, and UPMC.
- Kaiser Permanente's Abridge rollout across 40 hospitals and 600 clinics is considered the largest generative AI project in healthcare history.
- Abridge's valuation nearly doubled in just four months in 2025 — from $2.75B (February) to $5.3B (June) — on the back of a $300M Series E led by Andreessen Horowitz.
- A KUMC peer-reviewed study found Abridge reduced clinician cognitive load by 61%, and at Sutter Health 78% of clinicians reported improved work satisfaction.
Frequently asked questions
About this listing
This entry was compiled from publicly available data including Abridge's official website, press releases, documentation, and reputable third-party publications. RECATOOLS is not affiliated with Abridge unless explicitly stated.
Third-party AI tools update their pricing, features, availability, and policies frequently. Information here may be outdated by the time you read this — we make reasonable efforts to keep listings current, but cannot guarantee absolute accuracy.
For the latest details, please refer to Abridge directly →
Spotted something out of date? Suggest an update →
Related reading
Alternatives to Abridge
More in Healthcare
